Synopsys Stock - CEO sells $6.7 million in pre-planned share sale
17.06.2026 - 18:28:13 | ad-hoc-news.de
Edited by ad hoc news Operations & Strategy Desk. Verified prior to publication on 06/17/2026, 18:26 CET. Details in the imprint.
Synopsys (US8716071076) has reported a significant insider transaction by its chief executive. According to a Form 4 filing summarized by Investing.com, CEO Ghazi Sassine sold roughly $6.7 million of company stock after exercising options.
All news and analysis on Synopsys stock
Recent insider filings and analyst views put Synopsys stock under closer scrutiny as investors track execution in its core EDA and IP businesses.
What the latest Form 4 shows
On 06/15/2026, Synopsys CEO Ghazi Sassine exercised equity awards and sold 14,603 shares of common stock in open-market transactions at a weighted average price of about $458.96 per share, according to an SEC Form 4 reviewed via StockTitan. StockTitan summary of the Form 4 filing
The transaction formed part of a Rule 10b5-1 trading plan adopted on 09/19/2025, indicating it was pre-scheduled rather than opportunistic selling. After the trades, Sassine directly owns 75,020 Synopsys shares, the filing shows.
Additional insider equity activity
The CEO transaction followed other routine equity events at Synopsys. Chief Revenue Officer Michael Ellow reported vesting of 5,128 restricted stock units on 06/15/2026, with 2,543 shares withheld to cover tax obligations, according to a separate Form 4 also captured by StockTitan. StockTitan report on CRO RSU vesting
Following those RSU conversions and withholdings, Ellow holds 2,041 shares of Synopsys common stock directly, 16 shares indirectly via a family trust, and 26,713 remaining restricted stock units, underlining ongoing equity-based alignment with shareholders.
Analyst stance and valuation backdrop
Broker coverage remains measured despite the company’s strong position in electronic design automation. MarketBeat notes that 17 research firms currently cover Synopsys shares with a consensus recommendation of “Hold,” suggesting a cautious stance on upside from current levels. MarketBeat consensus rating overview
Investing.com data place the stock around $448.29 in recent trading, implying a market capitalization of roughly $86.08 billion. That backdrop helps frame the scale of the CEO’s roughly $6.7 million sale relative to Synopsys’s total equity value.
Operational focus and strategy
Operationally, Synopsys continues to build out its role as a core technology supplier to semiconductor designers. The company emphasizes AI-driven automation, advanced-node readiness and system-level verification as key pillars of its long-term growth strategy on its corporate site.
Management has also highlighted a shift toward more recurring and subscription-like revenue streams in recent years, with design software, IP licensing and associated services forming a more predictable base than traditional one-off license sales.
The product behind the stock
Synopsys makes its money primarily by selling electronic design automation software and semiconductor IP, with flagship tools such as its Design Compiler synthesis solution and the Fusion Compiler digital design platform widely used by chip designers worldwide.
Where the stock trades today
The shares of Synopsys (US8716071076) trade on Nasdaq at $448.29 as of 06/17/2026, 16:00 UTC.
Key facts on Synopsys stock
- Company: Synopsys Inc.
- ISIN: US8716071076
- WKN: 883703
- Ticker: SNPS
- Venue: Nasdaq
- Price (as of 06/17/2026, 16:00 UTC): 448.29 USD
- Market cap: 86,080,000,000 USD (as of 06/17/2026)
- Sector / Industry: Information Technology / Electronic Design Automation, Semiconductor IP
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
